BlackBerry Limited vs BIO-TECHNE Corp — how do they compare? BlackBerry Limited trades at $11.05 (market cap $6.26B), while BIO-TECHNE Corp trades at $71.23 (market cap $11.12B). The key difference: BIO-TECHNE Corp is the larger of the two by market cap, and BIO-TECHNE Corp pays a 0.45% dividend while BlackBerry Limited pays none. Which is the better fit depends on your goals.
| BB | TECH | |
|---|---|---|
Market Cap | $6.26B | $11.12B |
Sector | Technology | Health |
52-Week High | $12.81 | $71.38 |
52-Week Low | $3.15 | $43.31 |
Enterprise Value | $6.13B | $11.20B |
Dividend Yield | — | 0.45% |
Trailing returns across standard periods
BlackBerry Limited provides intelligent security software solutions. The Company offers artificial intelligence and machine learning for cybersecurity, safety, and data privacy solutions, as well as endpoint security and management, encryption, and embedded systems. BlackBerry serves governments and enterprise sectors worldwide.
Read more on BB →Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →